Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ID2 downregulation promotes tumor cell proliferation via elevated TCF3 activity in Multiple Myeloma [ATAC-seq]

ABSTRACT: Multiple myeloma (MM) is characterized by rewired transcriptional circuits. Transcription factors and their cofactors are major and selective non-oncogene dependencies in MM cells. By performing a gain-of-function (GOF) perturbation screen in MM cell lines, we identified the Inhibitor of DNA binding (ID) proteins as putative suppressors of MM cell fitness. Among the ID genes, ID2 was found to be downregulated in MM patient cells and acted as a tumor suppressor by directly binding and repressing the transcription factor TCF3. Lower ID2 expression in MM cells conferred a proliferative advantage by allowing higher TCF3 activity in tumor cells, resulting in a striking dependency on this TF. To the contrary, ID2 overexpression reduced TCF3 binding to DNA and rewired the MM transcriptome, leading to cell-cycle arrest and senescence. The myeloma bone marrow milieu participates in this process by further decreasing the expression of ID2 and enhancing TCF3 activity, revealing a novel mechanism by which the tumor microenvironment controls MM cell behavior.

ORGANISM(S): Homo sapiens

PROVIDER: GSE294108 | GEO | 2025/09/26

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

ID2 downregulation promotes tumor cell proliferation via elevated TCF3 activity in Multiple Myeloma [RNA-Seq]

Project description:Multiple myeloma (MM) is characterized by rewired transcriptional circuits. Transcription factors and their cofactors are major and selective non-oncogene dependencies in MM cells. By performing a gain-of-function (GOF) perturbation screen in MM cell lines, we identified the Inhibitor of DNA binding (ID) proteins as putative suppressors of MM cell fitness. Among the ID genes, ID2 was found to be downregulated in MM patient cells and acted as a tumor suppressor by directly binding and repressing the transcription factor TCF3. Lower ID2 expression in MM cells conferred a proliferative advantage by allowing higher TCF3 activity in tumor cells, resulting in a striking dependency on this TF. To the contrary, ID2 overexpression reduced TCF3 binding to DNA and rewired the MM transcriptome, leading to cell-cycle arrest and senescence. The myeloma bone marrow milieu participates in this process by further decreasing the expression of ID2 and enhancing TCF3 activity, revealing a novel mechanism by which the tumor microenvironment controls MM cell behavior.

2025-09-26 | GSE294106 | GEO

ID2 downregulation promotes tumor cell proliferation via elevated TCF3 activity in Multiple Myeloma [RNA-Seq]

Project description:ID2 downregulation promotes tumor cell proliferation via elevated TCF3 activity in Multiple Myeloma [RNA-Seq]

| PRJNA1248394 | ENA

ID2 downregulation promotes tumor cell proliferation via elevated TCF3 activity in Multiple Myeloma [ATAC-seq]

Project description:ID2 downregulation promotes tumor cell proliferation via elevated TCF3 activity in Multiple Myeloma [ATAC-seq]

| PRJNA1248397 | ENA

Identification of genes regulated by ID2 in Ewing sarcoma cells.

Project description:The ID family of proteins (ID1-4), which bind to basic helix-loop-helix (bHLH) transcription factors and prevent bHLH-directed transcription, are critical regulators of the differentiation and chemoresistance of cancer cells derived from multiple cellular lineages. ID2 was previously shown to impair the in vitro differentiation of human mesenchymal stem cells. However, the functional role, if any, of ID2 in regulating differentiation, developmental pathways, and the oncogenic phenotype of Ewing sarcoma tumors is unknown. We used CRISPR/Cas9 to knockout ID2 in Ewing sarcoma cell lines and identified that the loss of ID2 significantly decreases cell growth in vitro and in vivo in a xenograft experiment. Using RNA-seq and gene set enrichment analysis with ID2-knockout and ID2-Knockout-Rescue cell lines we identified that ID2 regulates genes related to differentiation and development in Ewing sarcoma cell lines.

2022-05-18 | GSE183658 | GEO

Id2 is required for antiviral Th1 cell differentiation and represses Tfh cell differentiation

Project description:Differentiation of naive CD4+ T cells into T-helper (Th) effector subsets is critical for protection against pathogens. Together, E-protein transcription factors and the inhibitor-of-DNA binding (Id) proteins are important arbiters of T cell development, but their role in the differentiation of Th1 and Tfh cells is not well understood. Th1 cells show robust Id2 expression compared to Tfh cells, and RNAi depletion of Id2 increased Tfh cell frequencies and germinal center responses, while impairing Th1 cell accumulation during viral infection. Further, Th1 cell differentiation was blocked by genetic ablation of Id2, leading to E-protein dependent accumulation of effector cells with 78% of Th1-associated genes showing diminished expression and a concurrent enrichment of the Tfh gene-expression program. The Tfh-defining transcriptional repressor Bcl6 bound to the Id2 locus inhibiting expression, providing a mechanism by which bimodal expression of Id2 in Tfh and Th1 cells can be established. Thus, Id2 is critical in enforcing the reciprocal development of Th1 and Tfh cell fates. We used microarray to assess the changes in gene expression between Id2-sufficient and -deficient Th1 and Tfh cells.

2016-05-23 | GSE74854 | GEO

Expression data from Id2-GFP- CDPs, Id2-GFP+ CDPs, Id2-GFP- pre-CD8, and Id2-GFP+ pre-CD8.

Project description:Expression data from Id2-GFP- CDPs, Id2-GFP+ CDPs, Id2-GFP- pre-CD8, and Id2-GFP+ pre-CD8.

| PRJNA509888 | ENA

A genetic circuitry linking Id-proteins (Id2 and Id3) and the AKT-FOXO-mTORC1 axis to suppress innate-variant TFH cell development, maintain T cell quiescence and prevent lymphomagenesis.

Project description:It is now well established that the E- and Id-protein axis regulates multiple steps in lymphocyte development. However, it remains unknown as to how E- and Id-proteins mechanistically enforce and maintain the naïve T cell fate. Here we show that Id2 and Id3 suppressed the development and expansion of innate-variant TFH cells. Innate-variant TFH cells required MHC Class I-like signalling and were associated with germinal center B cell development. We found that Id2 and Id3 induced Foxo1 and Foxp1 expression to antagonize the activation of TFH transcription signature. We show that Id2 and Id3 acted upstream of the Hif1a/Foxo/AKT/mTORC1 pathway as well as the c-myc/p19Arf module to control cellular expansion and activation. We found that mice depleted for Id2 and Id3 expression developed colitis and αβ T cell lymphomas. Lymphomas depleted for Id2 and Id3 expression displayed elevated levels of c-myc whereas p19Arf abundance declined. Transcription signatures of Id2- and Id3-depleted lymphomas revealed similarities with genetic deficiencies associated with Burkitt lymphoma. We propose that in response to antigen receptor and/or cytokine signaling the E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hifa and c-myc/p19Arf pathways to control cellular expansion and homeostatic proliferation.

2015-03-04 | GSE64779 | GEO

Wnt and Tcf3-mediated regulation of gene expression in mouse embryonic stem cells

Project description:The observation that Tcf3 (MGI name: Tcf7l1) bound the same genes as core stem cell transcription factors, Oct4 (MGI name:Pou5f1), Sox2 and Nanog, revealed a potentially important aspect of the poorly understood mechanism whereby Wnts stimulate self renewal of pluripotent mouse embryonic stem (ES) cells. Although the conventional view of Tcf proteins as the β-catenin-binding effectors of Wnt signaling suggested Tcf3 should activate target genes in response to Wnts, here we show that Wnt3a and Tcf3 effectively antagonize each other’s effects on gene expression. Genetic ablation of Tcf3 caused similar effects as treating cells with recombinant Wnt3a. Moreover, Tcf3 was not necessary for Wnt3a-stimulation of gene expression as the majority of Wnt3a-stimulated genes exhibited a greater increase in Tcf3-/- ES cells than in Tcf3+/+ ES cells. These expression data, together with genetic experiments, show that Wnt3a stimulates ES cell self renewal by inhibiting Tcf3. Tcf3+/+ and Tcf3-/- mouse embryonic stem cells were cultured in self renewal conditions containing recombinant Wnt3a for RNA extraction and hybridization on Affymetrix microarrays.

2011-02-24 | E-GEOD-27455 | biostudies-arrayexpress

Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3

Project description:Regulatory factors controlling stem cell identity and self-renewal are often active in aggressive cancers and are thought to promote their growth and progression. TCF3 (also known as TCF7L1) is a member of the TCF/LEF transcription factor family that is central in regulating epidermal and embryonic stem (ES) cell identity. We found that TCF3 is highly expressed in poorly differentiated human breast cancers, preferentially of the basal-like subtype. This suggested that TCF3 is involved in the regulation of breast cancer cell differentiation state and tumorigenicity. Silencing of TCF3 dramatically decreased the ability of breast cancer cells to initiate tumor formation, and led to decreased tumor growth rates. In culture, TCF3 promotes the sphere formation capacity of breast cancer cells and their self-renewal. We found that in contrast to ES cells, where it represses Wnt-pathway target genes, TCF3 promotes the expression of a subset of Wnt-responsive genes in breast cancer cells, while repressing another distinct target subset. In the normal mouse mammary gland Tcf3 is highly expressed in terminal end buds, structures that lead duct development. Primary mammary cells are dependent on Tcf3 for mammosphere formation, and its overexpression in the developing gland disrupts ductal growth. Our results identify TCF3 as a central regulator of tumor growth and initiation, and a novel link between stem cells and cancer. Cells infected with different shRNA vectors were either untreated, treated with control or Wnt3A condition medium. Condition medium treatments were done in biological repeats.

2012-10-23 | E-GEOD-38893 | biostudies-arrayexpress

Wnt and Tcf3-mediated regulation of gene expression in mouse embryonic stem cells

2011-02-24 | GSE27455 | GEO